| 发明名称 |
GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY |
| 摘要 |
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator. |
| 申请公布号 |
HK1213602(A1) |
申请公布日期 |
2016.07.08 |
| 申请号 |
HK20160101496 |
申请日期 |
2016.02.11 |
| 申请人 |
F. Hoffmann-La Roche AG |
发明人 |
DUB, Marie-Pierre -;NIESOR, Eric J. J;TARDIF, Jean-Claude -;UPMANYU, Ruchi |
| 分类号 |
C12Q |
主分类号 |
C12Q |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
